tacrine has been researched along with Atrophy in 2 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riekkinen, P | 4 |
| Soininen, H | 2 |
| Helkala, EL | 1 |
| Partanen, K | 1 |
| Laakso, M | 2 |
| Vanhanen, M | 1 |
| Riekkinen, M | 1 |
| Kuikka, J | 1 |
1 trial available for tacrine and Atrophy
| Article | Year |
|---|---|
Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Attention; Cerebrovascular Circulation; Cholinesterase Inhibitors; | 1997 |
1 other study available for tacrine and Atrophy
| Article | Year |
|---|---|
Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease.
Topics: Alzheimer Disease; Atrophy; Hippocampus; Humans; Learning; Memory; Neuropsychological Tests; Tacrine | 1995 |